Revolution Medicines, Inc. (RVMD) short interest & options flow
NASDAQRVMD has pulled away from its closest biotech peers in the week before its Q3 print, gaining 5.8% while the median move across its eight nearest correlates was a loss of 3.1%. SLS dropped 27% on the week, RLAY fell 7.4%, and IDYA lost 6.5%. Against that backdrop, RVMD's advance to $199.70 is conspicuous, and so is the short interest that has…
RVMD short interest jumps 21.8% over one week to 6.1% of free float, highest in 30 days, as cost to borrow rises to 0.55%.
- Market cap
- $42.80B
- Next earnings
- 5 Nov 2026
Key data as of 5 Nov 2026
Latest signals on RVMD
- Short Interest
RVMD short interest jumps 21.8% over one week to 6.1% of free float, highest in 30 days, as cost to borrow rises to 0.55%.
4 Short Interest updates in 30 days
RVMD news and analysis
RSSNo long-form analysis yet for RVMD. Pulse alerts and the live data picture are available on ORTEX.
Open RVMD on ORTEX →Want the live picture for RVMD?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RVMD — free to start on ORTEX.
Sign up for free →Open RVMD on ORTEX